Patient insights platform XO Life receives 2 million euros

XO Life relies on the integration of patient-reported outcomes (PRO) into its platform to record patient experiences with health conditions, medications and illnesses in a standardized and privacy-compliant manner. This data can be shared anonymously with the healthcare industry and used to develop precise, individual treatments and to assess patient benefits. To this end, the Munich-based start-up is working closely with leading research institutes such as the Promis Institut Germany at Charité and various pharmaceutical manufacturers. XO Life is financially supported by players from the medtech sector, including Seedlink, Mediventures and Aescuvest, with an investment of 2 million euros, which will primarily be used to further develop the platform.